| Authors: |
Elayoubi J; Department of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI., Tang C; Ataraxis AI, New York, NY., Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN., Choucair K; Department of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI., Kalinsky K; Winship Cancer Institute of Emory University, Atlanta, GA., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, National Research Institute of Oncology in Warsaw, Warsaw, Poland., Esteva FJ; Division of Hematology/Oncology, Northwell Health Cancer Institute, Lenox Hill Hospital, New York, NY., Abdelsattar JM; University of Arizona College of Medicine, Tucson, AZ., Borges VF; University of Colorado Anschutz Medical Campus, Aurora, CO., Zeng K; Ataraxis AI, New York, NY., Cappadona J; Ataraxis AI, New York, NY., Machura B; Ataraxis AI, New York, NY., Biswas D; Ataraxis AI, New York, NY., Geras KJ; Ataraxis AI, New York, NY., Witowski J; Ataraxis AI, New York, NY. Electronic address: jan.witowski@ataraxis.ai. |
